HFNC Vs LFNC in Patients with AF Undergoing RFCA Under Deep Sedation.
High Flow Nasal Cannula (HFNC) Versus Standard Low Flow Nasal Cannula (LFNC) in Patients with Atrial Fibrillation Undergoing Radiofrequency Catheter Ablation (RFCA) Under Deep Desaturation.
Sponsor: Maastricht University Medical Center
Terminated
Due to changes in logistics (indications Rf and attendance PFA), it has not been feasible to include the required number of participants in this study
Other terminated trials from Maastricht University Medical Center
- Atrophy, Muscle · Feb 2026
- Covid19 · Aug 2024
- Functional Dyspepsia · Phase PHASE3 · Aug 2024
- Healthy · May 2024
- Obesity · Phase NA · Apr 2024
See all terminations from Maastricht University Medical Center
A NA clinical study on Deep Sedation and Oxygen Therapy, this trial is terminated or withdrawn. The trial is conducted by Maastricht University Medical Center and has accumulated 6 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Mar 2025 — Present [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Sep 2024 — Mar 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Recruiting NA
-
Jan 2023 — May 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
May 2021 — Jan 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Maastricht University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .